查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152748

突變分析市場：市場規模、佔有率和趨勢分析（按突變類型、技術、產品/服務、最終用途和地區分類），基於細分市場的預測（2026-2033 年）

Mutational Analysis Market Size, Share & Trends Analysis Report By Mutation Type, By Technology, By Product & Service, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

突變分析市場概述

全球突變分析市場預計到 2025 年價值 20 億美元，到 2026 年將成長到 24 億美元，到 2033 年將成長到 75 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 17.9%。

北美市場領先，預計到 2025 年將佔銷售額的 42.8%。市場成長的促進因素包括次世代定序和分子譜分析技術的日益普及、對精準醫療日益成長的需求，以及突變分析在癌症基因組學、遺傳疾病診斷和藥物發現等領域的廣泛應用。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：市場波動因素、趨勢與範圍

  • 市場歷史及展望
  • 市場動態
  • 產業分析工具

第4章：依變異類型進行業務分析

  • 突變分析市場：按突變類型分類的趨勢分析
  • SNV/點方差
  • 印德爾
  • 拷貝編號變體
  • 結構突變
  • 迭代開發
  • 其他變化

第5章：依技術進行業務分析

  • 突變分析市場：依技術分類的趨勢分析
  • 基於定序
  • 基於PCR的
  • 基於微陣列
  • 利用 CRISPR 技術
  • 其他分子技術

第6章：依產品/服務進行業務分析

  • 突變分析市場：按產品和服務分類的趨勢分析
  • 設備/器材
  • 耗材和試劑
  • 軟體與生物資訊學
  • 測試和分析服務

第7章 依最終用途進行業務分析

  • 突變分析市場：依最終用途分類的趨勢分析
  • 臨床和診斷
  • 精準醫療
  • 研究與開發
  • 學術和研究機構/CRO（委外研發機構）
  • 其他

第8章：按地區分類的業務分析

  • 突變分析市佔率：按地區分類（2025-2033 年）
  • 北美洲
    • 北美突變分析市場（2021-2033）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲突變分析市場（2021-2033）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區突變分析市場（2021-2033）
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲突變分析市場（2021-2033）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲突變分析市場（2021-2033）
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 企業市場占有率及定位分析（2025 年）
  • 策略規劃
  • 公司簡介列表
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • F. Hoffmann-La Roche Ltd
    • QIAGEN
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies plc.
    • PacBio
    • Takara Bio Inc.
    • Revvity
Product Code: GVR-4-68041-039-3

Mutational Analysis Market Summary

The global mutational analysis market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 7.5 billion by 2033, at a CAGR of 17.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 42.8% in 2025. The market growth is driven by increasing adoption of next-generation sequencing and molecular profiling technologies, growing demand for precision medicine, and expanding applications of mutational analysis in cancer genomics, inherited disease diagnosis, and drug development.

Global Mutational Analysis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global mutational analysis market on the basis of mutation type, technology, product & service, end use, and region.

  • Mutation Type Outlook (Revenue, USD Million, 2021-2033)
  • SNVs/Point Mutations
  • Indels
  • Copy Number Variants
  • Structural Variants
  • Repeat Expansions
  • Other Mutations
  • Technology Outlook (Revenue, USD Million, 2021-2033)
  • Sequencing-based
  • PCR-based
  • Microarray-based
  • CRISPR-based
  • Other Molecular Methods
  • Product & Service Outlook (Revenue, USD Million, 2021-2033)
  • Instruments & Equipment
  • Consumables & Reagents
  • Software & Bioinformatics
  • Testing & Analytical Services
  • End Use Outlook (Revenue, USD Million, 2021-2033)
  • Clinical & Diagnostics
  • Precision Medicine
  • Research & Drug Development
  • Academic/CRO Research
  • Others
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Mutation Type Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Product & Service Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Comprehensive Detection of Genomic Mutations
      • 3.2.1.2. Rising Adoption of Mutation Analysis in Precision Oncology and Targeted Therapy
      • 3.2.1.3. Advancements in Sequencing Technologies for Mutation Detection
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Costs and Uneven Reimbursement for Mutation and Genomic Testing
      • 3.2.2.2. Technical Limitations in Detecting Complex and Low-Frequency Mutations
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. Mutation Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Mutational Analysis Market: Mutation Type Movement Analysis
  • 4.3. SNVs/Point Mutations
    • 4.3.1. SNVs/Point Mutations Market, 2021-2033 (USD Million)
  • 4.4. Indels
    • 4.4.1. Indels Market, 2021-2033 (USD Million)
  • 4.5. Copy Number Variants
    • 4.5.1. Copy Number Variants Market, 2021-2033 (USD Million)
  • 4.6. Structural Variants
    • 4.6.1. Structural Variants Market, 2021-2033 (USD Million)
  • 4.7. Repeat Expansions
    • 4.7.1. Repeat Expansions Market, 2021-2033 (USD Million)
  • 4.8. Other Mutations
    • 4.8.1. Other Mutations Market, 2021-2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Mutational Analysis Market: Technology Movement Analysis
  • 5.3. Sequencing-based
    • 5.3.1. Sequencing-based Market, 2021-2033 (USD Million)
  • 5.4. PCR-based
    • 5.4.1. PCR-based Market, 2021-2033 (USD Million)
  • 5.5. Microarray-based
    • 5.5.1. Microarray-based Market, 2021-2033 (USD Million)
  • 5.6. CRISPR-based
    • 5.6.1. CRISPR-based Market, 2021-2033 (USD Million)
  • 5.7. Other Molecular Methods
    • 5.7.1. Other Molecular Methods Market, 2021-2033 (USD Million)

Chapter 6. Product & Service Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Mutational Analysis Market: Product & Service Movement Analysis
  • 6.3. Instruments & Equipment
    • 6.3.1. Instruments & Equipment Market, 2021-2033 (USD Million)
  • 6.4. Consumables & Reagents
    • 6.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
  • 6.5. Software & Bioinformatics
    • 6.5.1. Software & Bioinformatics Market, 2021-2033 (USD Million)
  • 6.6. Testing & Analytical Services
    • 6.6.1. Testing & Analytical Services Market, 2021-2033 (USD Million) \

Chapter 7. End Use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Mutational Analysis Market: End Use Movement Analysis
  • 7.3. Clinical & Diagnostics
    • 7.3.1. Clinical & Diagnostics Market, 2021-2033 (USD Million)
  • 7.4. Precision Medicine
    • 7.4.1. Precision Medicine Market, 2021-2033 (USD Million)
  • 7.5. Research & Drug Development
    • 7.5.1. Research & Drug Development Market, 2021-2033 (USD Million)
  • 7.6. Academic/CRO Research
    • 7.6.1. Academic/CRO Research Market, 2021-2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2021-2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mutational Analysis Market Share By Region, 2025 & 2033
  • 8.2. North America
    • 8.2.1. North America Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. U.S. Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Canada Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Mexico Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. UK Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Germany Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. France Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Italy Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Spain Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Denmark Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Sweden Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Norway Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Japan Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. China Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. India Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Australia Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Thailand Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. South Korea Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Brazil Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Argentina Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. South Africa Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Saudi Arabia Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. UAE Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Kuwait Mutational Analysis Market, 2021-2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Share/ Position Analysis, 2025
  • 9.3. Strategy Mapping
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Type Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Illumina, Inc
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Type Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. F. Hoffmann-La Roche Ltd
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Type Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Type Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Type Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Type Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Oxford Nanopore Technologies plc.
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Type Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. PacBio
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Type Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Takara Bio Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Type Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Revvity
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Type Benchmarking
      • 9.4.10.4. Strategic Initiatives
      • 9.4.10.5. Overview
      • 9.4.10.6. Financial Performance
      • 9.4.10.7. Product Type Benchmarking
      • 9.4.10.8. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 4 Global mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 5 Global mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 6 Global mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 7 Global mutational analysis market, by region, 2021-2033 (USD million)
  • Table 8 North America mutational analysis market, by country, 2021-2033 (USD million)
  • Table 9 North America mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 10 North America mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 11 North America mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 12 North America mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 13 U.S. mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 14 U.S. mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 15 U.S. mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 16 U.S. mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 17 Canada mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 18 Canada mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 19 Canada mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 20 Canada mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 21 Mexico mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 22 Mexico mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 23 Mexico mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 24 Mexico mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 25 Europe mutational analysis market, by country, 2021-2033 (USD million)
  • Table 26 Europe mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 27 Europe mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 28 Europe mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 29 Europe mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 30 UK mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 31 UK mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 32 UK mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 33 UK mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 34 Germany mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 35 Germany mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 36 Germany mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 37 Germany mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 38 France mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 39 France mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 40 France mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 41 France mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 42 Italy mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 43 Italy mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 44 Italy mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 45 Italy mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 46 Spain mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 47 Spain mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 48 Spain mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 49 Spain mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 50 Denmark mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 51 Denmark mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 52 Denmark mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 53 Denmark mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 54 Sweden mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 55 Sweden mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 56 Sweden mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 57 Sweden mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 58 Norway mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 59 Norway mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 60 Norway mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 61 Norway mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 62 Asia Pacific mutational analysis market, by country, 2021-2033 (USD million)
  • Table 63 Asia Pacific mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 64 Asia Pacific mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 65 Asia Pacific mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 66 Asia Pacific mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 67 Japan mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 68 Japan mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 69 Japan mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 70 Japan mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 71 China mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 72 China mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 73 China mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 74 China mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 75 India mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 76 India mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 77 India mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 78 India mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 79 Australia mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 80 Australia mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 81 Australia mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 82 Australia mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 83 Thailand mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 84 Thailand mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 85 Thailand mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 86 Thailand mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 87 South Korea mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 88 South Korea mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 89 South Korea mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 90 South Korea mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 91 Latin America mutational analysis market, by country, 2021-2033 (USD million)
  • Table 92 Latin America mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 93 Latin America mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 94 Latin America mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 95 Latin America mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 96 Brazil mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 97 Brazil mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 98 Brazil mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 99 Brazil mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 100 Argentina mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 101 Argentina mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 102 Argentina mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 103 Argentina mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 104 Middle East & Africa mutational analysis market, by country, 2021-2033 (USD million)
  • Table 105 Middle East & Africa mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 106 Middle East & Africa mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 107 Middle East & Africa mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 108 Middle East & Africa mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 109 South Africa mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 110 South Africa mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 111 South Africa mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 112 South Africa mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 113 Saudi Arabia mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 114 Saudi Arabia mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 115 Saudi Arabia mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 116 Saudi Arabia mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 117 UAE mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 118 UAE mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 119 UAE mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 120 UAE mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 121 Kuwait mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 122 Kuwait mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 123 Kuwait mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 124 Kuwait mutational analysis market, by end use, 2021-2033 (USD million)

List of Figures

  • Fig. 1 Mutational analysis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Mutational analysis market driver analysis
  • Fig. 12 Mutational analysis market restraint analysis
  • Fig. 13 Mutational analysis market: Porter's five forces analysis
  • Fig. 14 Mutational analysis market: PESTLE analysis
  • Fig. 15 Mutational analysis market: mutation type outlook and key takeaways
  • Fig. 16 Mutational analysis market: mutation type market share analysis
  • Fig. 17 SNVs/point mutations market, 2021-2033 (USD million)
  • Fig. 18 Indels market, 2021-2033 (USD million)
  • Fig. 19 Copy number variants market, 2021-2033 (USD million)
  • Fig. 20 Structural variants market, 2021-2033 (USD million)
  • Fig. 21 Repeat expansions market, 2021-2033 (USD million)
  • Fig. 22 Other mutations market, 2021-2033 (USD million)
  • Fig. 23 Mutational analysis market: technology outlook and key takeaways
  • Fig. 24 Mutational analysis market: technology market share analysis
  • Fig. 25 Sequencing-based market, 2021-2033 (USD million)
  • Fig. 26 PCR-based market, 2021-2033 (USD million)
  • Fig. 27 Microarray-based market, 2021-2033 (USD million)
  • Fig. 28 CRISPR-based market, 2021-2033 (USD million)
  • Fig. 29 Other molecular methods market, 2021-2033 (USD million)
  • Fig. 30 Mutational analysis market: product & service outlook and key takeaways
  • Fig. 31 Mutational analysis market: product & service market share analysis
  • Fig. 32 Instruments & equipment market, 2021-2033 (USD million)
  • Fig. 33 Consumables & reagents market, 2021-2033 (USD million)
  • Fig. 34 Software & bioinformatics market, 2021-2033 (USD million)
  • Fig. 35 Testing & analytical services market, 2021-2033 (USD million)
  • Fig. 36 Mutational analysis market: end use outlook and key takeaways
  • Fig. 37 Mutational analysis market: end use market share analysis
  • Fig. 38 Clinical & diagnostics market, 2021-2033 (USD million)
  • Fig. 39 Precision medicine market, 2021-2033 (USD million)
  • Fig. 40 Research & drug development market, 2021-2033 (USD million)
  • Fig. 41 Academic/CRO research market, 2021-2033 (USD million)
  • Fig. 42 Others market, 2021-2033 (USD million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 45 U.S. mutational analysis market, 2021-2033 (USD million)
  • Fig. 46 Canada mutational analysis market, 2021-2033 (USD million)
  • Fig. 47 Mexico mutational analysis market, 2021-2033 (USD million)
  • Fig. 48 Europe mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 49 UK mutational analysis market, 2021-2033 (USD million)
  • Fig. 50 Germany mutational analysis market, 2021-2033 (USD million)
  • Fig. 51 France mutational analysis market, 2021-2033 (USD million)
  • Fig. 52 Italy mutational analysis market, 2021-2033 (USD million)
  • Fig. 53 Spain mutational analysis market, 2021-2033 (USD million)
  • Fig. 54 Denmark mutational analysis market, 2021-2033 (USD million)
  • Fig. 55 Sweden mutational analysis market, 2021-2033 (USD million)
  • Fig. 56 Norway mutational analysis market, 2021-2033 (USD million)
  • Fig. 57 Asia Pacific mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 58 Japan mutational analysis market, 2021-2033 (USD million)
  • Fig. 59 China mutational analysis market, 2021-2033 (USD million)
  • Fig. 60 India mutational analysis market, 2021-2033 (USD million)
  • Fig. 61 Australia mutational analysis market, 2021-2033 (USD million)
  • Fig. 62 Thailand mutational analysis market, 2021-2033 (USD million)
  • Fig. 63 South Korea mutational analysis market, 2021-2033 (USD million)
  • Fig. 64 Latin America mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 65 Brazil mutational analysis market, 2021-2033 (USD million)
  • Fig. 66 Argentina mutational analysis market, 2021-2033 (USD million)
  • Fig. 67 MEA mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 68 South Africa mutational analysis market, 2021-2033 (USD million)
  • Fig. 69 Saudi Arabia mutational analysis market, 2021-2033 (USD million)
  • Fig. 70 UAE mutational analysis market, 2021-2033 (USD million)
  • Fig. 71 Kuwait mutational analysis market, 2021-2033 (USD million)